These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 9186816

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Augmentation of growth hormone secretion after testosterone treatment in boys with constitutional delay of growth and adolescence: evidence against an increase in hypothalamic secretion of growth hormone-releasing hormone.
    Racine MS, Symons KV, Foster CM, Barkan AL.
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3326-31. PubMed ID: 15240610
    [Abstract] [Full Text] [Related]

  • 3. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
    Ghigo E, Imperiale E, Boffano GM, Mazza E, Bellone J, Arvat E, Procopio M, Goffi S, Barreca A, Chiabotto P.
    J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
    [Abstract] [Full Text] [Related]

  • 4. Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen in prepubertal and early pubertal short children.
    Guzzaloni G, Grugni G, Morabito F.
    Minerva Endocrinol; 1998 Dec; 23(4):99-104. PubMed ID: 10361807
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Growth hormone-releasing effect of oral growth hormone-releasing peptide 6 (GHRP-6) administration in children with short stature.
    Bellone J, Ghizzoni L, Aimaretti G, Volta C, Boghen MF, Bernasconi S, Ghigo E.
    Eur J Endocrinol; 1995 Oct; 133(4):425-9. PubMed ID: 7581965
    [Abstract] [Full Text] [Related]

  • 7. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
    Evans WS, Anderson SM, Hull LT, Azimi PP, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
    [Abstract] [Full Text] [Related]

  • 8. Effect of overnight constant infusion of human growth hormone (GH)-releasing hormone-(1-44) on 24-hour GH secretion in children with partial GH deficiency.
    Rochiccioli PE, Tauber MT, Uboldi F, Coude FX, Morre M.
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1100-5. PubMed ID: 3093519
    [Abstract] [Full Text] [Related]

  • 9. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency.
    Tzanela M, Guyda H, Van Vliet G, Tannenbaum GS.
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2487-94. PubMed ID: 8675565
    [Abstract] [Full Text] [Related]

  • 10. Hexarelin, a synthetic GH-releasing peptide, is a powerful stimulus of GH secretion in pubertal children and in adults but not in prepubertal children and in elderly subjects.
    Bellone J, Bartolotta E, Sgattoni C, Aimaretti G, Arvat E, Bellone S, Deghenghi R, Ghigo E.
    J Endocrinol Invest; 1998 Sep; 21(8):494-500. PubMed ID: 9801989
    [Abstract] [Full Text] [Related]

  • 11. The effects of acute and chronic growth hormone (GH) administration on GH secretion in patients with idiopathic GH deficiency.
    Hanew K, Goh M, Sato S, Shimizu Y, Sasaki A, Aida M, Yoshinaga K.
    J Clin Endocrinol Metab; 1988 Apr; 66(4):715-21. PubMed ID: 3126213
    [Abstract] [Full Text] [Related]

  • 12. The effects of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion.
    Eakman GD, Dallas JS, Ponder SW, Keenan BS.
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1217-23. PubMed ID: 8772602
    [Abstract] [Full Text] [Related]

  • 13. Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in man.
    Arvat E, Maccagno B, Ramunni J, Gianotti L, Di Vito L, Deghenghi R, Camanni F, Ghigo E.
    J Endocrinol Invest; 1997 Mar; 20(3):122-7. PubMed ID: 9186817
    [Abstract] [Full Text] [Related]

  • 14. Contribution of growth hormone-releasing hormone and somatostatin to decreased growth hormone secretion in elderly men.
    Soule SG, Macfarlane P, Levitt NS, Millar RP.
    S Afr Med J; 2001 Mar; 91(3):254-60. PubMed ID: 11291426
    [Abstract] [Full Text] [Related]

  • 15. Pretreatment with somatostatin analog SMS 201-995 potentiates growth hormone (GH) responsiveness to GH-releasing factor in short children.
    Dickerman Z, Guyda H, Tannenbaum GS.
    J Clin Endocrinol Metab; 1993 Sep; 77(3):652-7. PubMed ID: 8257527
    [Abstract] [Full Text] [Related]

  • 16. Chronic growth hormone administration does not suppress endogenous growth hormone secretion in patients with neurosecretory growth hormone dysfunction.
    Zadik Z, Limoni Y, Lieberman E.
    Horm Res; 1991 Sep; 35(3-4):95-8. PubMed ID: 1806474
    [Abstract] [Full Text] [Related]

  • 17. Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency.
    Rochiccioli PE, Tauber MT, Coude FX, Arnone M, Morre M, Uboldi F, Barbeau C.
    J Clin Endocrinol Metab; 1987 Aug; 65(2):268-74. PubMed ID: 3110202
    [Abstract] [Full Text] [Related]

  • 18. Alterations in spontaneous growth hormone (GH) secretion and the response to GH-releasing hormone in children with nonorganic nutritional dwarfing.
    Abdenur JE, Pugliese MT, Cervantes C, Fort P, Lifshitz F.
    J Clin Endocrinol Metab; 1992 Sep; 75(3):930-4. PubMed ID: 1517388
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone (GH) release after administration of GH-releasing hormone in relation to endogenous 24-h GH secretion in short children.
    Gelander L, Albertsson-Wikland K.
    J Endocrinol; 1989 Jul; 122(1):61-8. PubMed ID: 2549156
    [Abstract] [Full Text] [Related]

  • 20. The growth hormone response to hexarelin in patients with Prader-Willi syndrome.
    Cappa M, Raguso G, Palmiotto T, Faedda A, Gurreri F, Neri G, Deghenghi R, Loche S.
    J Endocrinol Invest; 1998 Sep; 21(8):501-5. PubMed ID: 9801990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.